100 Mg Arsenic Trioxide Injection

Name: 100 Mg Arsenic Trioxide Injection
Brand: NEETCO BIOPHARMA
Price: 400 INR
Availability: InStock

Price 400 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

100 Mg Arsenic Trioxide Injection Specification

Indication
Acute promyelocytic leukemia (APL)

Dosage Form
Injection

Salt Composition
Arsenic Trioxide 10 mg/mL (100 mg/10 mL) injection

Feature
Cytotoxic antineoplastic, ready-to-use presentation

Ingredients
Arsenic Trioxide, Water for Injection, Sodium Hydroxide, Hydrochloric Acid

Application
Intravenous use for treatment of APL

Ph Level
pH 7.0 8.0

Physical Color/Texture
Clear, colorless sterile solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

Regulatory Approval
Approved by Drug Regulatory Authority

Warning
Cytotoxichandle with care

Strength
100 mg/10 mL vial

Solubility
Fully soluble in water

Container Type
Glass vial

Prescription Status
Prescription only (Rx)

Pack Size
Single-use vial

USP/Pharmacopoeia
Complies with USP standards

Precaution
For hospital use only

Disposal Method
Dispose according to biomedical waste guidelines

Administration Route
Intravenous infusion only

Marketed By
Marketed under various brands

Compatibility
Compatible with 0.9% sodium chloride

About 100 Mg Arsenic Trioxide Injection

The 100 mg Arsenic Trioxide Injection is a top-ranking cytotoxic antineoplastic solution, renowned for its flawless compliance with USP standards. Offered in a single-use glass vial, this cost-effective product ensures the lowest price for hospital use in India. Intravenous infusion is the only administration route, and purchase requires a valid prescription. Fully soluble in water and compatible with 0.9% sodium chloride, it is meticulously marketed by trusted brands. Disposal must follow biomedical guidelines, ensuring safety. Regulatory-approved, it's ideal for treating acute promyelocytic leukemia with a shelf life of 24 months.

Competitive Advantages & Applications

100 mg Arsenic Trioxide Injection is used to treat acute promyelocytic leukemia (APL) due to its high efficacy. Its competitive advantages include flawless solubility, ready-to-use presentation, and strict adherence to USP safety standards. It's trusted in hospitals and oncology centers nationwide for intravenous application, combining renowned quality with effective cytotoxic action. The clear, colorless solution makes handling seamless, positioning this injection among the most preferred choices for APL treatment in India.

Sample Availability, Market Reach & Delivery

Samples of 100 mg Arsenic Trioxide Injection are available for medical professionals to assess hospital compatibility. The main domestic market covers India, with punctual delivery timeframes maintained by reliable suppliers. Packing & dispatch are efficiently organized, ensuring every vial is securely sealed. Quotations are promptly provided, and drop-off services adapt to facility needs, establishing dependable support for distributors, exporters, and traders looking to stock this essential cytotoxic antineoplastic agent.

FAQ's of 100 Mg Arsenic Trioxide Injection:

Q: How is 100 mg Arsenic Trioxide Injection administered for patients with APL?

A: 100 mg Arsenic Trioxide Injection is administered exclusively via intravenous infusion in hospital settings, ensuring precise dosing and optimal therapeutic outcomes for acute promyelocytic leukemia (APL).

Q: What precautions must be taken when handling the injection?

A: Due to its cytotoxic nature, the injection should be handled with care by trained hospital staff following strict safety protocols. Proper disposal according to biomedical waste guidelines is essential.

Q: Where can this injection be purchased and who is eligible to buy it?

A: This medication is available from licensed distributors, exporters, and suppliers across India. Purchase requires a valid prescription and is restricted to hospitals and approved medical facilities.

Q: When should the injection be used for patient treatment?

A: It is indicated for use in the treatment of acute promyelocytic leukemia (APL) under hospital supervision, as determined by a medical specialist's prescription and assessment.

Q: What competitive benefits does this product offer for hospitals?

A: The product provides cost-effective, ready-to-use presentation, compatibility with 0.9% sodium chloride, compliance with USP standards, and a long shelf life, making it efficient and convenient for hospital use.